Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial

INTRODUCTION: Calcium pyrophosphate deposition (CPPD) may cause severe arthropathy, major joint destruction and treatment options are limited. The aim of this study was to test the therapeutic efficacy of methotrexate (MTX) in chronic or recurrent CPPD arthropathy. METHODS: Patients with CPPD arthro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Finckh, Axel, Mc Carthy, Geraldine M, Madigan, Anne, Van Linthoudt, Daniel, Weber, Marcel, Neto, David, Rappoport, Georges, Blumhardt, Sandra, Kyburz, Diego, Guerne, Pierre-Andre
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223155/
https://ncbi.nlm.nih.gov/pubmed/25315665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-014-0458-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados